No connection

Search Results

ABBV vs ITGR

ABBV
AbbVie Inc.
NEUTRAL
Price
$219.26
Market Cap
$387.52B
Sector
Healthcare
AI Confidence
68%
ITGR
Integer Holdings Corporation
NEUTRAL
Price
$84.64
Market Cap
$2.91B
Sector
Healthcare
AI Confidence
85%

Valuation

P/E Ratio
ABBV
163.63
ITGR
29.29
Forward P/E
ABBV
15.42
ITGR
11.71
P/B Ratio
ABBV
-146.66
ITGR
1.66
P/S Ratio
ABBV
6.5
ITGR
1.57
EV/EBITDA
ABBV
15.27
ITGR
11.17

Profitability

Gross Margin
ABBV
71.46%
ITGR
27.39%
Operating Margin
ABBV
35.5%
ITGR
12.79%
Profit Margin
ABBV
4.0%
ITGR
5.55%
ROE
ABBV
137.96%
ITGR
6.11%
ROA
ABBV
9.59%
ITGR
4.75%

Growth

Revenue Growth
ABBV
9.1%
ITGR
5.0%
Earnings Growth
ABBV
-88.7%
ITGR
52.9%

Financial Health

Debt/Equity
ABBV
--
ITGR
0.75
Current Ratio
ABBV
0.72
ITGR
3.32
Quick Ratio
ABBV
0.47
ITGR
2.05

Dividends

Dividend Yield
ABBV
3.05%
ITGR
--
Payout Ratio
ABBV
490.15%
ITGR
0.0%

AI Verdict

ABBV NEUTRAL

The Advanced Deterministic Scorecard reveals a mixed health profile with a Piotroski F-Score of 4/9 indicating stable but not strong fundamentals, while the absence of an Altman Z-Score prevents a clear distress risk assessment. Despite robust operating margins and consistent revenue growth, the company faces significant headwinds from negative earnings growth, an extremely high P/E ratio, and a dangerously elevated payout ratio. Strong historical price performance and analyst buy sentiment are counterbalanced by bearish insider activity and deteriorating profitability trends. The stock appears to trade at a substantial premium to its intrinsic value, suggesting limited margin of safety.

Strengths
High operating margin (35.50%) indicating strong pricing power and cost control
Consistent revenue growth (9.10% YoY) outpacing sector average
Strong track record of earnings surprises (22 out of 25 quarters beat estimates)
Risks
Extremely high P/E ratio (163.63) vs forward P/E (15.42), suggesting potential overvaluation on trailing basis
Earnings growth collapsing (YoY: -88.70%, Q/Q: -88.10%) indicating severe profitability deterioration
Unsustainable dividend payout ratio (490.15%) threatening dividend security
ITGR NEUTRAL

Integer Holdings (ITGR) presents a dichotomy between strong forward-looking earnings potential and weak current market sentiment. The Piotroski F-Score of 4/9 indicates stable but not robust financial health, while the stock is currently trading almost exactly at its growth-based intrinsic value of $85.26, leaving no margin of safety. While the trailing P/E is high, the Forward P/E of 11.71 and explosive YoY earnings growth of 52.9% suggest a significant valuation correction is underway. However, a bearish technical trend and negative insider sentiment temper the bullish analyst consensus.

Strengths
Exceptional short-term liquidity with a Current Ratio of 3.32
Strong earnings acceleration with 52.9% YoY growth
Attractive Forward P/E (11.71) compared to trailing P/E (29.29)
Risks
Lack of margin of safety as price ($84.64) equals intrinsic value ($85.26)
Stagnant revenue growth (5% YoY) suggesting earnings growth is driven by cost-cutting rather than expansion
Bearish technical trend (0/100) and negative insider sentiment

Compare Another Pair

ABBV vs ITGR: Head-to-Head Comparison

This page compares AbbVie Inc. (ABBV) and Integer Holdings Corporation (ITGR) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI Chat
Markets
Profile